December 31, 2024 The company is exploring the potential for continued development of its norovirus vaccine candidates in adults ...
Q4 2024 Earnings Call Transcript March 27, 2025 BioRestorative Therapies, Inc. beats earnings expectations. Reported EPS is $ ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback